Clinical Trial Update: Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patient-controlled sedation using propofol and remifentanil for ERCP has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endoscopic Retrograde Cholangiopancreatography

Drugs mentioned

• PROPOFOL (Propofol)
• Remifentanil (remifentanil)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Endoscopic Retrograde Cholangiopancreatography | Phase 4 | Status: COMPLETED